Filing Details

Accession Number:
0001179110-15-005250
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2015-03-19 17:46:32
Reporting Period:
2015-03-17
Filing Date:
2015-03-19
Accepted Time:
2015-03-19 17:46:32
Original Submission Date:
2015-03-19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1065087 Albany Molecular Research Inc AMRI Services-Commercial Physical & Biological Research (8731) 141742717
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1449207 R Steven Hagen 26 Corporate Circle
Albany NY 12203
Svp Manufacturing & Pharmaceut No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-17 3,500 $8.90 34,700 No 4 M Direct
Common Stock Disposition 2015-03-17 3,500 $18.53 31,200 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Acquisiton 2015-03-17 3,500 $8.90 3,500 $8.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,000 2020-03-08 No 4 M Direct
Footnotes
  1. 100% of grant is time based. Time based grant vests 20% per year on each of the first 5 anniversaries of the date of grant (March 8, 2010). The 3,500 shares being exercised represent a portion of the vested grant.